22 Aug, 2020

Histopathological findings and clinicopathologic correlation in COVID-19: a systematic review

The severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2) pandemic has had devastating effects on global health and worldwide economy. Despite an initial reluctance to perform autopsies due to concerns for aerosolization of viral particles, a large number of autopsy studies published since May 2020 have shed light on the pathophysiology of Coronavirus disease 2019 (COVID-19).

15 Jul, 2020

Diffuse alveolar damage (DAD) resulting from coronavirus disease 2019 Infection is Morphologically Indistinguishable from Other Causes of DAD

An aim of this study was to assess lung autopsy findings in COVID-19 inpatients, and in untreated severe acute respiratory syndrome coron- avirus 2 (SARS-CoV-2)-positive individuals who died in the community...

05 Jan, 2020

EURACAN IASLC proposals for updating the histologic classification of pleural mesothelioma towards a more multidisciplinary approach

PD-L1 IHC 22C3 pharmDx is the only companion diagnostic FDA-approved as an aid in identifying patients with head and neck squamous cell carcinoma (HNSCC) for treatment with KEYTRUDA® (pembrolizumab). This Interpretation Manual is provided as a tool to help guide pathologists and laboratory personnel in achieving correct and reproducible results in assessing PD-L1 expression in FFPE HNSCC specimens.